GGrantIndex
Sort

146,196 grants matching diabetes

Novel Biomarkers and Prediction Models for Rheumatoid Arthritis

$785,824
Elizabeth W Karlson · Brigham And Women'S Hospital · R01 · FY2017 · AR

Oxidation-mediated structural degeneration of bioprosthetic heart valves

$785,792
Robert J Levy · Children'S Hosp Of Philadelphia · R01 · FY2020 · HL

Modeling diabetes using an integrated plate system

$785,782
James M Wells · Cincinnati Childrens Hosp Med Ctr · UG3 · FY2019 · DK

NHGRI/DIR Microarray and single-cell Core

$785,780
Abdel Elkahloun · National Human Genome Research Institute · ZIC · FY2019 · HG

Database and Biorepository Core

$785,729
Jeffrey P Krischer · Baylor College Of Medicine · U54 · FY2018 · DK

Role of Smooth Muscle Cell Insulin Resistance and Systemic Metabolic Dysfunction in Atherosclerosis Development and Late Stage Lesion Pathogenesis

$785,723
Gary K Owens · University Of Virginia · R01 · FY2024 · HL

Sleep-Disordered Breathing and Outcomes in Chronic Kidney Disease

$785,721
Ana Catherine Ricardo · University Of Illinois At Chicago · R01 · FY2019 · DK

Hydrogels for human beta cell survival, function and evasion of immune rejection

$785,689
Andres J Garcia · Georgia Institute Of Technology · R01 · FY2024 · DK

Epigenetic roles in regulation of cholesterol metabolism and CVD risk

$785,637
Yongmei Liu · Wake Forest University Health Sciences · R01 · FY2015 · HL

Regulation of Myocardial Phospholipases and Lipases in Diabetic Myocardium

$785,597
Richard W Gross · Washington University · R01 · FY2022 · HL

Adipose tissue mediates cardiac metabolic remodeling in the pathologically stressed heart in the absence of primary metabolic stress

$785,561
E Douglas Lewandowski · Ohio State University · R01 · FY2023 · HL

Adipose tissue mediates cardiac metabolic remodeling in the pathologically stressed heart in the absence of primary metabolic stress

$785,561
E Douglas Lewandowski · Ohio State University · R01 · FY2025 · HL

Cellular Basis Of Action Of Gastrointestinal Peptides/Growth factors

$785,515
Robert Jensen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK

Affordable Oral Delivery of Human Therapeutic Proteins Bioencapsulated in Plant Cells

$785,508
Henry Daniell · University Of Pennsylvania · R01 · FY2021 · HL

Massive-scale genomic risk assessment to inform precision medicine across the spectrum of monogenic and common forms of diabetes

$785,491
Josep Maria Mercader · Broad Institute, Inc. · R01 · FY2025 · DK

ApoE2 and protective molecular signatures in Alzheimer's disease and aging

$785,423
Alexander M Kulminski · Duke University · R01 · FY2019 · AG

Improving Blood Pressure Screening and Treatment Strategies in Young Adults

$785,423
Jaejin An · Kaiser Foundation Research Institute · R01 · FY2021 · HL

Altered Glucose and Lipid Metabolism in Obesity and CVD

$785,418
Maureen J Charron · Albert Einstein College Of Medicine · R01 · FY2007 · HL

ImmGen: a gene expression compendium for immune cells

$785,364
Christophe O Benoist · Harvard Medical School · R24 · FY2010 · AI

Clinical and Translational Core

$785,340
Bradley J Willcox · Kuakini Medical Center · P20 · FY2023 · GM

Developing A Novel Therapy for Diabetic Retinopathy

$785,308
Danyang Chen · Charlesson, Llp · R44 · FY2015 · EY

BEST-VIVA Registry (vCLI)

$785,298
Manesh R Patel · Duke University · R01 · FY2019 · HL

Allergen Loaded Nanoparticles for Food Allergy Tolerance

$785,246
Lonnie D Shea · University Of Michigan At Ann Arbor · R01 · FY2020 · AI

The Neuropathologic Landscape of Alzheimer's Disease in Hispanic Decedents

$785,243
Brittany Nicole Dugger · University Of California At Davis · R01 · FY2019 · AG

Testing for Preclinical efficacy in prevention or reversal of Type 1 Diabetes (T1

$785,216
Alex Poorman · Biomedical Research Models, Inc. · N01 · FY2011 · DK